Targeted therapy in metastatic renal cell carcinoma: efficacy, adverse-event management and key considerations
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Amsterdam [u.a.]
Elsevier
2007
|
Schriftenreihe: | EJC
Supplements ; 5,7 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | 34 S. Ill. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV023008905 | ||
003 | DE-604 | ||
005 | 20080327 | ||
007 | t | ||
008 | 071119s2007 a||| |||| 00||| eng d | ||
035 | |a (OCoLC)254137394 | ||
035 | |a (DE-599)BVBBV023008905 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-19 |a DE-20 | ||
245 | 1 | 0 | |a Targeted therapy in metastatic renal cell carcinoma |b efficacy, adverse-event management and key considerations |
264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2007 | |
300 | |a 34 S. |b Ill. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a EJC : Supplements |v 5,7 | |
650 | 0 | 7 | |a Metastase |0 (DE-588)4125915-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hypernephrom |0 (DE-588)4161076-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Hypernephrom |0 (DE-588)4161076-3 |D s |
689 | 0 | 1 | |a Metastase |0 (DE-588)4125915-4 |D s |
689 | 0 | 2 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
689 | 0 | |5 DE-604 | |
830 | 0 | |a EJC |v Supplements ; 5,7 |w (DE-604)BV017615175 |9 5,7 | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016213148&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-016213148 |
Datensatz im Suchindex
_version_ | 1804137222436290560 |
---|---|
adam_text | IT5 EJC SUPPLEMENTS
2007
Contents
Targeted therapy in metastatic renal cell carcinoma: efficacy, adverse event
management and key considerations
Targeted therapy in metastatic renal cell carcinoma: efficacy, adverse event management and key
considerations
A. Rauaud 1
Current options for the treatment of locally advanced and metastatic renal cell carcinoma: focus
on sunitinib
A. Rauaud 4
Optimisation of sunitinib therapy in metastatic renal cell carcinoma: adverse event management
S. Negrier, A. Rauaud 12
Key considerations in patient selection for the use of targeted therapy in
metastatic renal cell carcinoma
A. Rauaud 20
Case Report 1. Sunitinib malate in patients with pre existing haematological abnormalities
A. Bamias 28
Case Report 2. Severe erythema multiforme induced by two consecutive anti angiogenic drugs
M.S. Dilhuydy, T. Jouary, A. Gomez, H. Walkrand, G. Pastkier, A. Rauaud 30
Case Report 3. Sunitinib malate in patients with cerebellar metastases
S. Negrier 32
*gM»g gftgfc Indexed/Abstracted in:
3||||I|||||| Current Contents;
jSgBSrar^ EMBASE/Excerpta Medica; icnuMco/in
y*PNtP $i , , w j ,,cnnUr ISSN 1359 6349
^^a Index Medicus; MEDLINE;
ft 4fn»C CABS, BIOS/S Database;
ELSEVIER PASCAL CNRS Database; CINAHLs®
|
adam_txt |
IT5 EJC SUPPLEMENTS
2007
Contents
Targeted therapy in metastatic renal cell carcinoma: efficacy, adverse event
management and key considerations
Targeted therapy in metastatic renal cell carcinoma: efficacy, adverse event management and key
considerations
A. Rauaud 1
Current options for the treatment of locally advanced and metastatic renal cell carcinoma: focus
on sunitinib
A. Rauaud 4
Optimisation of sunitinib therapy in metastatic renal cell carcinoma: adverse event management
S. Negrier, A. Rauaud 12
Key considerations in patient selection for the use of targeted therapy in
metastatic renal cell carcinoma
A. Rauaud 20
Case Report 1. Sunitinib malate in patients with pre existing haematological abnormalities
A. Bamias 28
Case Report 2. Severe erythema multiforme induced by two consecutive anti angiogenic drugs
M.S. Dilhuydy, T. Jouary, A. Gomez, H. Walkrand, G. Pastkier, A. Rauaud 30
Case Report 3. Sunitinib malate in patients with cerebellar metastases
S. Negrier 32
*gM»g gftgfc Indexed/Abstracted in:
3||||I|||||| Current Contents;
jSgBSrar^ EMBASE/Excerpta Medica; icnuMco/in
y*PNtP $i , , w j ,,cnnUr ISSN 1359 6349
^^a Index Medicus; MEDLINE;
ft 4fn»C CABS, BIOS/S Database;
ELSEVIER PASCAL CNRS Database; CINAHLs® |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
building | Verbundindex |
bvnumber | BV023008905 |
ctrlnum | (OCoLC)254137394 (DE-599)BVBBV023008905 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01469nam a2200361 cb4500</leader><controlfield tag="001">BV023008905</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080327 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">071119s2007 a||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)254137394</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023008905</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeted therapy in metastatic renal cell carcinoma</subfield><subfield code="b">efficacy, adverse-event management and key considerations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">34 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">EJC : Supplements</subfield><subfield code="v">5,7</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Metastase</subfield><subfield code="0">(DE-588)4125915-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypernephrom</subfield><subfield code="0">(DE-588)4161076-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hypernephrom</subfield><subfield code="0">(DE-588)4161076-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Metastase</subfield><subfield code="0">(DE-588)4125915-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">EJC</subfield><subfield code="v">Supplements ; 5,7</subfield><subfield code="w">(DE-604)BV017615175</subfield><subfield code="9">5,7</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016213148&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016213148</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV023008905 |
illustrated | Illustrated |
index_date | 2024-07-02T19:08:36Z |
indexdate | 2024-07-09T21:08:52Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016213148 |
oclc_num | 254137394 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 |
owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 |
physical | 34 S. Ill. |
publishDate | 2007 |
publishDateSearch | 2007 |
publishDateSort | 2007 |
publisher | Elsevier |
record_format | marc |
series | EJC |
series2 | EJC : Supplements |
spelling | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations Amsterdam [u.a.] Elsevier 2007 34 S. Ill. txt rdacontent n rdamedia nc rdacarrier EJC : Supplements 5,7 Metastase (DE-588)4125915-4 gnd rswk-swf Hypernephrom (DE-588)4161076-3 gnd rswk-swf Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Hypernephrom (DE-588)4161076-3 s Metastase (DE-588)4125915-4 s Targeted drug delivery (DE-588)4302415-4 s DE-604 EJC Supplements ; 5,7 (DE-604)BV017615175 5,7 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016213148&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations EJC Metastase (DE-588)4125915-4 gnd Hypernephrom (DE-588)4161076-3 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
subject_GND | (DE-588)4125915-4 (DE-588)4161076-3 (DE-588)4302415-4 (DE-588)4143413-4 |
title | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations |
title_auth | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations |
title_exact_search | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations |
title_exact_search_txtP | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations |
title_full | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations |
title_fullStr | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations |
title_full_unstemmed | Targeted therapy in metastatic renal cell carcinoma efficacy, adverse-event management and key considerations |
title_short | Targeted therapy in metastatic renal cell carcinoma |
title_sort | targeted therapy in metastatic renal cell carcinoma efficacy adverse event management and key considerations |
title_sub | efficacy, adverse-event management and key considerations |
topic | Metastase (DE-588)4125915-4 gnd Hypernephrom (DE-588)4161076-3 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
topic_facet | Metastase Hypernephrom Targeted drug delivery Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016213148&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV017615175 |